IDEXX Laboratories Inc (IDXX)

152.89
NASDAQ : Health Care
Prev Close 152.89
Day Low/High 0.00 / 0.00
52 Wk Low/High 74.48 / 153.94
Avg Volume 1.12M
Exchange NASDAQ
Shares Outstanding 88.01M
Market Cap 13.45B
EPS 2.50
P/E Ratio 62.66
Div & Yield N.A. (N.A)

Latest News

Here's a Look at the 64 Best Performing Stocks Over the Last 4 Months

Here's a Look at the 64 Best Performing Stocks Over the Last 4 Months

The top 64 companies taking a trip to TheStreet's 2017 Market Bracket Challenge tournament.

Idexx Laboratories: Why I'm Avoiding This Puppy

Idexx Laboratories: Why I'm Avoiding This Puppy

Households now spend more on their pets than cable TV.

Bonds Call the Tune Today, Not Stocks: Cramer's 'Mad Money' Recap (Thursday 2/9/17)

Bonds Call the Tune Today, Not Stocks: Cramer's 'Mad Money' Recap (Thursday 2/9/17)

When bond yields rise, the economy roars and it's game on for industrials, banks and retailers, says Jim Cramer.

Cramer: Reward vs. Political Risk

Cramer: Reward vs. Political Risk

Trump has made it harder to decide how much volatility you can stand.

Jim Cramer -- Idexx Labs Isn't Done Rallying

Jim Cramer -- Idexx Labs Isn't Done Rallying

Idexx Laboratories beat on earnings per share and revenue expectations, but the trend is still good, Cramer said.

Amazon, Merck, Freshpet: Jim Cramer's Views

Amazon, Merck, Freshpet: Jim Cramer's Views

Cramer shares his views on the pajama traders, and talks turkey about pet stocks.

Jim Cramer's Top Takeaways: VCA, Johnson Controls, Adient

Jim Cramer's Top Takeaways: VCA, Johnson Controls, Adient

Cramer can't understand why shares of Johnson Controls spinoff Adient aren't trading higher.

These Stocks Are Too Hot, in a Bad Way : Jim Cramer's 'Mad Money' Recap

These Stocks Are Too Hot, in a Bad Way : Jim Cramer's 'Mad Money' Recap

Going into earnings what the market needs now is more negativity, Cramer says.

Cramer: Barking Up the Right Tree With Pet Health Stocks

Cramer: Barking Up the Right Tree With Pet Health Stocks

The Mars-VCA deal is yet another sign that pet health is a robust business.

Mars Makes 'Breakthrough Deal' With VCA Acquisition: More Squawk From Jim Cramer

Mars Makes 'Breakthrough Deal' With VCA Acquisition: More Squawk From Jim Cramer

Mars is making moves in 'one of the fastest growing secular stories in the world' with its acquisition of VCA, TheStreet's Jim Cramer said.

Jim Cramer on the Mars Deal for VCA

Jim Cramer on the Mars Deal for VCA

Jim Cramer says the deal between Mars and VCA is another example of how pet pampering is becoming big business.

Jim Cramer's Top Takeaways: Western Digital, Diamondback Energy, IDEXX Laboratories

Jim Cramer's Top Takeaways: Western Digital, Diamondback Energy, IDEXX Laboratories

From data storage and oil markets to the 'humanization of pets,' these stocks are worth a closer look.

Jim Cramer's 'Mad Money' Recap: How to Play Leapfrog in This Fast-Moving Market

Jim Cramer's 'Mad Money' Recap: How to Play Leapfrog in This Fast-Moving Market

Jim Cramer says stocks keep leapfrogging their peers in sectors like airlines and semiconductors.

'Mad Money' Lightning Round: Jim Cramer Likes Some Banks on a Pullback

'Mad Money' Lightning Round: Jim Cramer Likes Some Banks on a Pullback

Bank of America is a buy, Jim Cramer says. And Morgan Stanley is also cheap.

Jim Cramer's 'Mad Money' Recap: In This Market, Buyers Are Underneath

Jim Cramer's 'Mad Money' Recap: In This Market, Buyers Are Underneath

Jim Cramer says buyers just can't wait for this market to come down.

Jim Cramer -- Buy Zoetis, Idexx Over Freshpet

Jim Cramer -- Buy Zoetis, Idexx Over Freshpet

Jim Cramer says Freshpet is only a takeover play and suggests buying Zoetis or Idexx Labs instead.

'Mad Money' Lightning Round: Cramer's Been Behind MGM Resorts for a Long Time

'Mad Money' Lightning Round: Cramer's Been Behind MGM Resorts for a Long Time

MGM: 'I like the CEO and I like the REIT,' Jim Cramer says.

Jim Cramer's 'Mad Money' Recap: The Three Faces of the Stock Market

Jim Cramer's 'Mad Money' Recap: The Three Faces of the Stock Market

Know which stocks are interest-rate sensitive and which don't care, says Jim Cramer.

Bet on Animal Health By Investing in Idexx Laboratories, Analysts Say

Bet on Animal Health By Investing in Idexx Laboratories, Analysts Say

The animal health industry looks poised for growth, analysts say, and Idexx Laboratories IDXX stands to benefit.